XML 21 R8.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Consolidated Schedule of Investments
3 Months Ended
Mar. 31, 2024
Notes to Financial Statements  
Investment Holdings [Text Block]

Firsthand Technology Value Fund, Inc.

 

Consolidated Schedule of Investments

 

MARCH 31, 2024 (UNAUDITED)

 

 

 

PORTFOLIO

                      

COMPANY

                      

(% OF NET

                      

ASSETS)

    Interest       

SHARES/PAR

         

AND INDUSTRY

TYPE OF INVESTMENT

Maturity

 

Rate

  

ACQUISITION DATE

 

VALUE ($)

  

COST BASIS

  

VALUE

 

EQX CAPITAL, INC.

(37.6%)

                      

Equipment Leasing

Common Stock *(1)(2)(4)

      6/10/2016 

 

  100,000  $20,000  $9 

 

 

Preferred Stock - Series A *(1)(2)(4)

      

6/10/2016

-

11/7/2016

  1,950,000   1,950,000   63,148 
         

 

 

          63,157 
         

 

 

            

HERA SYSTEMS, INC.

(1880.9%)

        

 

 

            

Aerospace

Convertible Note (1)(2)(4)(6)

12/31/2024

  10%  

12/29/2022

 

 

  5,359,791   5,359,791   2,580,617 
 

Convertible Note (1)(2)(4)

12/31/2024  10%  12/29/2022 

 

  1,200,000   1,200,000   577,772 
 

Preferred Stock - Series A *(1)(2)(4)

      9/18/2015

 

 

  3,642,324   2,000,000   0 
 

Preferred Stock - Series B *(1)(2)(4)

      8/7/2017-2/1/2019  7,039,203   6,587,102   0 
 

Preferred Stock - Series C *(1)(2)(4)

      

8/7/2019

-

2/12/2020

  2,650,000   2,650,000   0 
 

Preferred Stock Warrants - Series B *(1)(2)(4)

      7/9/2018-

9/4/2018

  12,250,000   0   0 
 

Preferred Stock Warrants - Series B *(1)(2)(4)

      2/1/2019

 

 

  5,250,000   0   0 
 

Preferred Stock Warrants - Series B *(1)(2)(4)

      8/7/2017

 

 

  6,214,922   0   0 
 

Preferred Stock Warrants - Series B *(1)(2)(4)

      

9/28/2017

 

 

  700,000   0   0 
         

 

 

          3,158,389 
         

 

 

            

INTRAOP MEDICAL CORP. (74.7%) Medical Devices

Convertible Note (1)(2)(4)(6)

12/31/2024  15%  

10/11/2019

 

 

  500,000   500,000   2,255 
 

Convertible Note (1)(2)(4)(6)

12/31/2024

  15%  

10/22/2021

 

 

  1,000,000   1,000,000   4,511 
 

Convertible Note (1)(2)(4)(6)

12/31/2024

  15%  

10/29/2019

 

 

  500,000   500,000   2,255 

 

See accompanying notes to financial statements

 

 

PORTFOLIO

                      

COMPANY

                      

(% OF NET

                      

ASSETS)

           

SHARES/PAR

         

AND INDUSTRY

TYPE OF INVESTMENT

Maturity

 

Interest Rate

  

ACQUISITION DATE

 

VALUE ($)

  

COST BASIS

  

VALUE

 

INTRAOP MEDICAL CORP. (continued)

Convertible Note (1)(2)(4)(6)

12/31/2024

  15%  10/6/2021    500,000  $500,000  $2,256 
 

Convertible Note (1)(2)(4)(6)

12/31/2024  15%  11/12/2021    500,000   500,000   2,256 
 

Convertible Note (1)(2)(4)(6)

12/31/2024  15%  11/29/2021    500,000   500,000   2,256 
 

Convertible Note (1)(2)(4)(6)

12/31/2024  15%  12/31/2018    10,961,129   10,961,129   49,448 
 

Convertible Note (1)(2)(4)(6)

12/31/2024  15%  2/27/2020    1,000,000   1,000,000   4,511 
 

Convertible Note (1)(2)(4)(6)

12/31/2024  15%  2/28/2022    200,000   200,000   902 
 

Convertible Note (1)(2)(4)(6)

12/31/2024  15%  3/252020    500,000   500,000   2,256 
 

Convertible Note (1)(2)(4)(6)

12/31/2024  15%  3/30/2022    150,000   150,000   677 
 

Convertible Note (1)(2)(4)(6)

12/31/2024

  15%  4/20/2021    1,000,000   1,000,000   4,511 
 

Convertible Note (1)(2)(4)(6)

12/31/2024  15%  4/6/2022    350,000   350,000   1,579 
 

Convertible Note (1)(2)(4)(6)

12/31/2024  15%  3/8/2020    400,000   400,000   1,804 
 

Convertible Note (1)(2)(4)(6)

 12/31/2024

  15%  6/10/2021    500,000   500,000   2,256 
                       

 

See accompanying notes to financial statements

 

PORTFOLIO

                    

COMPANY

                    

(% OF NET

                    

ASSETS)

         

SHARES/PAR

         

AND INDUSTRY

TYPE OF INVESTMENT

MATURITY

 

INTEREST RATE

  

ACQUISITION DATE

 

VALUE ($)

  

COST BASIS

  

VALUE

 

INTRAOP MEDICAL CORP. (continued)

Convertible Note (1)(2)(4)(6)

12/31/2024  15%  

6/10/2022

  700,000  $700,000  $3,158 
 

Convertible Note (1)(2)(4)(6)

12/31/2024  15%  

7/12/2019

  1,300,000   1,300,000   5,864 
 

Convertible Note (1)(2)(4)(6)

12/31/2024

  15%  

7/16/2021

  500,000   500,000   2,256 
 

Convertible Note (1)(2)(4)(6)

12/31/2024

  15%  

7/31/2020

  500,000   500,000   2,256 
 

Convertible Note (1)(2)(4)(6)

12/31/2024

  15%  

8/28/2020

  750,000   750,000   3,383 
 

Convertible Note (1)(2)(4)(6)

12/31/2024  15%  9/22/2021  500,000   500,000   2,256 
 

Preferred Stock - Series C *(1)(2)(4)

      7/12/2013  26,856,187   26,299,939   0 
 

Term Note (1)(2)(4)(6)

12/31/2024  8%  

2/10/2017

  2,000,000   2,000,000   9,022 
 

Term Note (1)(2)(4)(6)

12/31/2024

  8%  2/28/2014  3,000,000   3,000,000   13,534 
                 125,462 

LYNCEAN TECHNOLOGIES, INC. (0.0%)

Semiconductor Equipment

Preferred Stock - Series B *(1)(4)

      

7/3/2018

  869,792   1,000,000   0 

 

See accompanying notes to financial statements

 

PORTFOLIO

                      

COMPANY

                      

(% OF NET

                      

ASSETS)

           

SHARES/PAR

         

AND INDUSTRY

TYPE OF INVESTMENT

MATURITY

 

INTEREST

RATE

  

ACQUISITION DATE

 

VALUE ($)

  

COST BASIS

  

VALUE

 

REVASUM, INC.

(601.9%)

Semiconductor Equipment

CDIs *(2)(4)

     11/14/2016-

10/3/2022

  39,774,889  $9,268,218  $1,010,659 
                      

UCT COATINGS, INC.

(175.6%)

Advanced Materials

Common Stock *(1)(3)(4)

     

4/18/2011

    1,500,000   662,235   294,836 
                      

WRIGHTSPEED, INC.

                     

(0.0%)

Automotive

Common Stock *(1)(2)(4)

     

6/7/2019

    69,102   7,460,851   0 
 

Convertible Note (1)(2)(4)(6)

6/30/2024

  12%  1/10/2023    100,000   100,000   0 
 

Convertible Note (1)(2)(4)(6)

6/30/2024  12%  

10/23/2020

    1,050,000   1,050,000   0 
 

Convertible Note (1)(2)(4)(6)

6/30/2024  12%  10/20/2021    1,000,000   1,000,000   0 
 

Convertible Note (1)(2)(4)(6)

6/30/2024

  12%  

10/21/2022

    135,000   135,000   0 
 

Convertible Note (1)(2)(4)(6)

6/30/2024

  12%  

 10/5/2021

    700,000   700,000   0 
 

Convertible Note (1)(2)(4)(6)

6/30/2024

  12%  

11/11/2020

    400,000   400,000   0 
 

Convertible Note (1)(2)(4)(6)

6/30/2024

  12%  

11/14/2022

    165,000   165,000   0 
 

Convertible Note (1)(2)(4)(6)

6/30/2024

  12%  

11/23/2021

    1,000,000   1,000,000   0 
 

Convertible Note (1)(2)(4)(6)

6/30/2024

  12%  

11/24/2020

    375,000   375,000   0 

 

See accompanying notes to financial statements

 

PORTFOLIO

                      

COMPANY

                      

(% OF NET

                      

ASSETS)

           

SHARES/PAR

         

AND INDUSTRY

TYPE OF INVESTMENT

MATURITY

 

INTEREST RATE

  

ACQUISITION DATE

 

VALUE ($)

  

COST BASIS

  

VALUE

 

WRIGHTSPEED, INC. (continued)

Convertible Note (1)(2)(4)(6)

6/30/2024  12%  

12/11/2020

    400,000  $400,000  $0 
 

Convertible Note (1)(2)(4)(6)

6/30/2024  12%  

12/23/2020

    2,000,000   2,000,000   0 
 

Convertible Note (1)(2)(4)(6)

6/30/2024  12%  

12/28/2021

    1,000,000   1,000,000   0 
 

Convertible Note (1)(2)(4)(6)

6/30/2024  12%  

12/9/2022

    125,000   125,000   0 
 

Convertible Note (1)(2)(4)(6)

6/30/2024  12%  

2/23/2021

    1,400,000   1,400,000   0 
 

Convertible Note (1)(2)(4)(6)

6/30/2024  12%  

2/23/2022

    200,000   200,000   0 
 

Convertible Note (1)(2)(4)(6)

6/30/2024  12%  3/11/2022    185,000   185,000   0 
 

Convertible Note (1)(2)(4)(6)

6/30/2024  12%  

4/12/2021

    1,200,000   1,200,000   0 
 

Convertible Note (1)(2)(4)(6)

6/30/2024  12%  

4/14/2022

    65,000   65,000   0 
 

Convertible Note (1)(2)(4)(6)

6/30/2024  12%  

5/10/2022

    250,000   250,000   0 
 

Convertible Note (1)(2)(4)(6)

6/30/2024  12%  

5//18/2021

    1,000,000   1,000,000   0 
 

Convertible Note (1)(2)(4)(6)

6/30/2024  12%  

5/26/2022

    250,000   250,000   0 

 

See accompanying notes to financial statements

 

PORTFOLIO

                      

COMPANY

                      

(% OF NET

                      

ASSETS)

           

SHARES/PAR

         

AND INDUSTRY

TYPE OF INVESTMENT

MATURITY

 

INTEREST RATE

  

ACQUISITION DATE

 

VALUE ($)

  

COST BASIS

  

VALUE

 

WRIGHTSPEED, INC. (continued)

Convertible Note (1)(2)(4)(6)

6/30/2024  12%  

6/10/2022

    250,000  $250,000  $0 
 

Convertible Note (1)(2)(4)(6)

6/30/2024  12%  

6/22/2021

    1,000,000   1,000,000   0 
 

Convertible Note (1)(2)(4)(6)

6/30/2024  12%  

6/28/2022

    250,000   250,000   0 
 

Convertible Note (1)(2)(4)(6)

6/30/2024  12%  

6/7/2019

    4,929,015   4,929,015   0 
 

Convertible Note (1)(2)(4)(6)

6/30/2024  12%  

7/13/2022

    250,000   250,000   0 
 

Convertible Note (1)(2)(4)(6)

6/30/2024  12%  

7/26/2021

    1,000,000   1,000,000   0 
 

Convertible Note (1)(2)(4)(6)

6/30/2024  12%  

7/28/ 2022

    250,000   250,000   0 
 

Convertible Note (1)(2)(4)(6)

6/30/2024  12%  

8/12/2020

    750,000   750,000   0 
 

Convertible Note (1)(2)(4)(6)

6/30/2024  12%  

8/12/2022

    250,000   250,000   0 
 

Convertible Note (1)(2)(4)(6)

6/30/2024  12%  

8/19/2021

    1,000,000   1,000,000   0 
 

Convertible Note (1)(2)(4)(6)

6/30/2024  12%  

9/10/2022

    900,000   900,000   0 
 

Convertible Note (1)(2)(4)(6)

6/30/2024  12%  

9/22/2021

    300,000   300,000   0 

 

See accompanying notes to financial statements

 

PORTFOLIO

                      

COMPANY

                      

(% OF NET

                      

ASSETS)

           

SHARES/PAR

         

AND INDUSTRY

TYPE OF INVESTMENT

MATURITY

 

INTEREST RATE

  

ACQUISITION DATE

 

VALUE ($)

  

COST BASIS

  

VALUE

 

WRIGHTSPEED, INC. (continued)

Convertible Note (1)(2)(4)(6)

12/31/2024

  18%  

7/25/2023

    40,000  $40,000  $0 
 

Preferred Stock - Series AA *(1)(2)(4)

     

6/7/2019

-

7/20/2020

  60,733,693   17,355,887   0 
                    0 
                      
                      

INVESTMENT COMPANY (25.7%)

Fidelity Investments Money Market Treasury Portfolio - Class I (5)

     

Various

    43,239   43,239   43,239 
                      

TOTAL INVESTMENTS (Cost $133,837,406) —2796.4%

 

                  $4,695,742 
                      

LIABILITIES IN EXCESS OF OTHER ASSETS — (2696.4)%

                   (4,527,822)
                      

NET ASSETS — 100.0%

                  $167,920 

 

All investments except the Fidelity Investments Money Market Portfolio are considered qualifying investments.

CDI: CHESS Depositary Interests

* 

Non-income producing security.

(1)

Restricted security. Fair Value is determined by or under the direction of the Company’s Board of Directors (see Note 3). At March 31, 2024, we held $3,641,844 (or 2168.8% of net assets) in restricted securities (see Note 2).

(2)

Controlled investments.

(3)

Affiliated issuer.

(4)

Fair Value Level 3 security (2770.7% of net assets).

(5)

The Fidelity Investments Money Market Treasury Portfolio invests primarily in U.S. Treasury securities.

(6)

Security whose interest accrues until maturity however, based on March 31, 2024 valuation no such interest accrued during period ended March 31, 2024.

 

See accompanying notes to financial statements

 

 

Firsthand Technology Value Fund, Inc.

 

Consolidated Schedule of Investments - continued

 

DECEMBER 31, 2023

 

 

PORTFOLIO

              

COMPANY

              

(% OF NET

              

ASSETS)

   INTEREST      

SHARES/PAR

    

AND INDUSTRY

TYPE OF INVESTMENT

MATURITY

 

RATE

 

ACQUISITION DATE

VALUE ($)

COST BASIS

VALUE

EQX CAPITAL, INC. (8.8)%

Common Stock *(1)(2)(4)

    

June 10, 2016

   100,000$20,000$55

Equipment Leasing

Preferred Stock - Series A *(1)(2)(4)

    

June 10, 2016

-

11/72016

 1,950,000 1,950,000 110,172
      

 

       110,227
      

 

        

HERA SYSTEMS, INC. (333.2%) Aerospace

Convertible Note (1)(2)(4)

12/31/2024

 10% 12/29/2022   1,200,000 1,200,000 768,317
 

Convertible Note (1)(2)(4)(6)

12/31/2024

 10% 

12/29/2022

   5,359,791 5,359,791 3,431,683
 

Preferred Stock - Series A *(1)(2)(4)

    

9/18/2015

   3,642,324 2,000,000 0
 

Preferred Stock - Series B *(1)(2)(4)

    

8/7/2017

-

2/1/2019

 7,039,203 6,587,102 0
 

Preferred Stock - Series C *(1)(2)(4)

    

8/7/2019

-

2/12/2020

 2,650,000 2,650,000 0
 

Preferred Stock Warrants - Series B *(1)(2)(4)

    

7/9/2018

-

9/4/2018

 12,250,000 0 0
 

Preferred Stock Warrants - Series B *(1)(2)(4)

    

2/1/2019

   5,250,000 0 0
 

Preferred Stock Warrants - Series B *(1)(2)(4)

    

8/7/2017

   6,214,922 0 0
 

Preferred Stock Warrants - Series B *(1)(2)(4)

    

9/28/2017

   700,000 0 0
             4,200,000
               

INTRAOP MEDICAL CORP. (7.0)% Medical Devices

Convertible Note (1)(2)(4)(6)

12/31/2024 15% 

12/31/2018

   10,961,129 10,961,129 34,570
 

Convertible Note (1)(2)(4)(6)

12/31/2024 15% 

7/12/2019

   1,300,000 1,300,000 4,100
 

Convertible Note (1)(2)(4)(6)

12/31/2024 15% 

10/11/2019

   500,000 500,000 1,577

 

See accompanying notes to financial statements

 

 

PORTFOLIO

                     

COMPANY

                     

(% OF NET

                     

ASSETS)

          

SHARES/PAR

         

AND INDUSTRY

TYPE OF INVESTMENT

MATURITY

 

INTEREST RATE

 

ACQUISITION DATE

 

VALUE ($)

  

COST BASIS

  

VALUE

 

INTRAOP MEDICAL CORP. (continued)

Convertible Note (1)(2)(4)(6)

12/31/2024  15% 

10/29/2019

    500,000  $500,000  $1,577 
 

Convertible Note (1)(2)(4)(6)

12/31/2024  15% 

2/27/2020

    1,000,000   1,000,000   3,154 
 

Convertible Note (1)(2)(4)(6)

12/31/2024  15% 

3/25/2020

    500,000   500,000   1,577 
 

Convertible Note (1)(2)(4)(6)

12/31/2024  15% 

5/8/2020

    400,000   400,000   1,261 
 

Convertible Note (1)(2)(4)(6)

12/31/2024  15% 

7/31/2020

    500,000   500,000   1,577 
 

Convertible Note (1)(2)(4)(6)

12/31/2024  15% 

7/28/2020

    750,000   750,000   2,365 
 

Convertible Note (1)(2)(4)(6)

12/31/2024  15% 

4/20/2021

    1,000,000   1,000,000   3,154 
 

Convertible Note (1)(2)(4)(6)

12/31/2024  15% 

6/10/2021

    500,000   500,000   1,577 
 

Convertible Note (1)(2)(4)(6)

12/31/2024  15% 

7/16/2021

    500,000   500,000   1,577 
 

Convertible Note (1)(2)(4)(6)

12/31/2024  15% 

9/22/2021

    500,000   500,000   1,577 
 

Convertible Note (1)(2)(4)(6)

12/31/2024  15% 

10/6/2021

    500,000   500,000   1,577 
 

Convertible Note (1)(2)(4)(6)

12/31/2024      15% 

10/22/2021

    1,000,000   1,000,000   3,154 

 

See accompanying notes to financial statements

 

PORTFOLIO

                   

COMPANY

                   

(% OF NET

                   

ASSETS)

        

SHARES/PAR

         

AND INDUSTRY

TYPE OF INVESTMENT

MATURITY

 

INTEREST RATE

 

ACQUISITION DATE

 

VALUE ($)

  

COST BASIS

  

VALUE

 

INTRAOP MEDICAL CORP. (continued)

Convertible Note (1)(2)(4)(6)

12/31/2024  15% 

11/12//2021

  500,000  $500,000  $1,577 
 

Convertible Note (1)(2)(4)(6)

12/31/2024  15% 

11/29/2021

  500,000   500,000   1,577 
 

Convertible Note (1)(2)(4)(6)

12/31/2024  15% 

2/28/2022

  200,000   200,000   631 
 

Convertible Note (1)(2)(4)(6)

12/31/2024  15% 

3/30/2022

  150,000   150,000   473 
 

Convertible Note (1)(2)(4)(6)

12/31/2024  15% 

4/6/2022

  350,000   350,000   1,104 
 

Convertible Note (1)(2)(4)(6)

12/31/2024  15% 

6/10/2022

  700,000   700,000   2,208 
 

Preferred Stock - Series C *(1)(2)(4)

     

7/12/2013

  26,856,187   26,299,938   0 
 

Term Note Matures (1)(2)(4)(6)

12/31/2024  8% 

2/28/2014

  3,000,000   3,000,000   9,461 
 

Term Note Matures (1)(2)(4)(6)

12/31/2024  8% 

2/10/2017

  2,000,000   2,000,000   6,308 
                  87,713 
                    

KYMA, INC. (7.9)%

Advanced Materials

Convertible Note (1)(4)

3/30/2024

  10% 

3/1//2019

  100,000   100,000   100,000 
                    

LYNCEAN TECHNOLOGIES, INC. (0.0)%

Preferred Stock - Series B *(1)(4)

     

7/3/2018

  869,792   1,000,000   0 

Semiconductor Equipment

                   

 

See accompanying notes to financial statements

 

PORTFOLIO

                     

COMPANY

                     

(% OF NET

                     

ASSETS)

          

SHARES/PAR

         

AND INDUSTRY

TYPE OF INVESTMENT

MATURITY

 

INTEREST RATE

 

ACQUISITION DATE

 

VALUE ($)

  

COST BASIS

  

VALUE

 

REVASUM, INC. (306.5%)

CDIs *(2)

    

11/14/2016

-

10/3/2022

  39,774,889  $9,268,219  $3,862,405 

Semiconductor Equipment

     

 

              
      

 

              

UCT COATINGS, INC. (23.8%)

Common Stock *(1)(3)(4)

    

4/18/2011

    1,500,000   662,235   299,932 

Advanced Materials

                    
                     

WRIGHTSPEED, INC. (0.0%)

Common Stock *(1)(2)(4)

    

4/11/2013

-

5/6//2019

  69,102   7,460,851   0 

Automotive

Convertible Note (1)(2)(4)(6)

6/30/2024

  12% 

6/7/2019

    4,929,015   4,929,015   0 
 

Convertible Note (1)(2)(4)(6)

6/30/2024

  12% 

8/12/2020

    750,000   750,000   0 
 

Convertible Note (1)(2)(4)(6)

6/30/2024

  12% 

9/10/2020

    900,000   900,000   0 
 

Convertible Note (1)(2)(4)(6)

6/30/2024  12% 

10/13/2020

    1,050,000   1,050,000   0 
 

Convertible Note (1)(2)(4)(6)

6/30/2024  12% 

11/11/2020

    400,000   400,000   0 
 

Convertible Note (1)(2)(4)(6)

6/30/2024  12% 

11/24/2020

    375,000   375,000   0 
 

Convertible Note (1)(2)(4)(6)

6/30/2024  12% 

12/11/2020

    400,000   400,000   0 
 

Convertible Note (1)(2)(4)(6)

6/30/2024

  12% 

12/23/2020

    2,000,000   2,000,000   0 

 

See accompanying notes to financial statements

 

PORTFOLIO

                     

COMPANY

                     

(% OF NET

                     

ASSETS)

          

SHARES/PAR

         

AND INDUSTRY

TYPE OF INVESTMENT

MATURITY

 

INTEREST RATE

 

ACQUISITION DATE

 

VALUE ($)

  

COST BASIS

  

VALUE

 
WRIGHTSPEED, INC. (continued)

Convertible Note (1)(2)(4)(6)

6/30/2024  12% 

2/23/2021

    1,400,000   1,400,000   0 
 

Convertible Note (1)(2)(4)(6)

6/30/2024

  12% 

4/12/2021

    1,200,000   1,200,000   0 
 

Convertible Note (1)(2)(4)(6)

6/30/2024  12% 

5/18/2021

    1,000,000   1,000,000   0 
 

Convertible Note (1)(2)(4)(6)

6/30/2024  12% 

6/22/2021

    1,000,000   1,000,000   0 
 

Convertible Note (1)(2)(4)(6)

6/30/2024  12% 

7/26/2021

    1,000,000   1,000,000   0 
 

Convertible Note (1)(2)(4)(6)

6/30/2024  12% 

8/19/2021

    1,000,000   1,000,000   0 
 

Convertible Note (1)(2)(4)(6)

6/30/2024  12% 

9/22/2021

    300,000   300,000   0 

 

See accompanying notes to financial statements

 

PORTFOLIO

                     

COMPANY

                     

(% OF NET

                     

ASSETS)

          

SHARES/PAR

         

AND INDUSTRY

TYPE OF INVESTMENT

MATURITY

 

INTEREST RATE

 

ACQUISITION DATE

 

VALUE ($)

  

COST BASIS

  

VALUE

 

WRIGHTSPEED, INC. (continued)

Convertible Note (1)(2)(4)(6)

6/30/2024  12% 10/5/2021    700,000  $700,000  $0 
 

Convertible Note (1)(2)(4)(6)

6/30/2024  12% 

10/20/2021

    1,000,000   1,000,000   0 
 

Convertible Note (1)(2)(4)(6)

6/30/2024  12% 

11/23/2021

    1,000,000   1,000,000   0 
 

Convertible Note (1)(2)(4)(6)

6/30/2024  12% 

12/28/2021

    1,000,000   1,000,000   0 
 

Convertible Note (1)(2)(4)(6)

6/30/2024        12% 

2/23/2022

    200,000   200,000   0 
 

Convertible Note (1)(2)(4)(6)

6/30/2024  12% 

3/11/2022

    185,000   185,000   0 
 

Convertible Note (1)(2)(4)(6)

6/30/2024  12% 

4/14/2022

    65,000   65,000   0 
 

Convertible Note (1)(2)(4)(6)

6/30/2024  12% 

5/10/2022

    250,000   250,000   0 
 

Convertible Note (1)(2)(4)(6)

6/30/2024  12% 

5/26/2022

    250,000   250,000   0 
 

Convertible Note (1)(2)(4)(6)

6/30/2024  12% 

6/10/2022

    250,000   250,000   0 
 

Convertible Note (1)(2)(4)(6)

6/30/2024

  12% 

6/28/2022

    250,000   250,000   0 
 

Convertible Note (1)(2)(4)(6)

6/30/2024  12% 

7/13/2022

    250,000   250,000   0 

 

See accompanying notes to financial statements

 

PORTFOLIO

                     

COMPANY

                     

(% OF NET

                     

ASSETS)

          

SHARES/PAR

         

AND INDUSTRY

TYPE OF INVESTMENT

MATURITY

 

INTEREST RATE

 

ACQUISITION DATE

 

VALUE ($)

  

COST BASIS

  

VALUE

 

WRIGHTSPEED, INC. (continued)

Convertible Note (1)(2)(4)(6)

6/30/2024  12% 

7/28/2022

    250,000  $250,000  $0 
 

Convertible Note (1)(2)(4)(6)

6/30/2024  12% 

8/12/2022

    250,000   250,000   0 
 

Convertible Note (1)(2)(4)(6)

6/30/2024  12% 

10/21/2022

    135,000   135,000   0 
 

Convertible Note (1)(2)(4)(6)

6/30/2024  12% 

11/14/2022

    165,000   165,000   0 
 

Convertible Note (1)(2)(4)(6)

6/30/2024  12% 

12/9/2022

    125,000   125,000   0 
 

Preferred Stock - Series AA *(1)(2)(4)

    

6/7/2019

-

7/20/2020

  60,733,693   17,355,887   0 
 

Preferred Stock Warrants - Series AA *(1)(2)(4)

    

6/7/2019

 

 

  609,756   0   0 
                 0 

 

See accompanying notes to financial statements

 

PORTFOLIO               
COMPANY              
(% OF NET              
ASSETS)   SHARES/PAR         
AND INDUSTRYTYPE OF INVESTMENTACQUISITION DATE VALUE ($)  COST BASIS  VALUE 

INVESTMENT COMPANY

(5.8%)

Fidelity Investments Money Market Treasury Portfolio - Class I (5)

Various

  73,502  $73,502  $73,502 
               

TOTAL INVESTMENTS

(Cost $133,967,669) —

693.0%

         $8,733,779 
               

LIABILITIES IN EXCESS OF OTHER ASSETS —

(593.0)%

          (7,473,408)
               

NET ASSETS — 100.0%

         $1,260,371 

 

All investments except the Fidelity Investments Money Market Portfolio are considered qualifying investments.

CDI: CHESS Depositary Interest.

* 

Non-income producing security.

 

(1)

Restricted security. Fair Value is determined by or under the direction of the Company’s Board of Directors (See note 3). At December 31, 2023, we held $4,797,872 (or 380.7% of net assets) in restricted securities (see Note 2).

(2)

Controlled investments.

(3)

Affiliated issuer.

(4)

Fair Value Level 3 security. (380.7% of net assets).

(5)

The Fidelity Investments Money Market Treasury Portfolio invests primarily in U.S. Treasury securities.

(6)

Security whose interest accrues until maturity however, based on December 31, 2023 valuation no such interest accrued during year ended December 31, 2023.

 

See accompanying notes to financial statements